Why Lupkynis?
A treatment that helps you take on the challenge
LUPKYNIS is helping to transform the way lupus nephritis is treated
Helps control lupus nephritis
For people taking LUPKYNISa, the chance of getting their lupus nephritis under controlb after one year of treatment was almost 3 times greaterc than for people only taking mycophenolate mofetil (MMF) and steroids.
Lowered the dose of steroids needed
In clinical trials, LUPKYNIS helped to stop the attack of lupus nephritis with low-dose steroids.
Reduces protein in urine
In clinical trials, LUPKYNIS helped reduce protein in the urine (called proteinuria, a key sign of disease activity) roughly 2x fasterd than MMF and steroids alone.
People taking LUPKYNIS saw a 50% reduction of proteinuria, on average after just one month.
Studied across different races and ethnicities
LUPKYNIS was tested in clinical studies that involved more than 350 people across different races and ethnicities.
aAs part of a treatment plan that included mycophenolate mofetil and steroids.
bControl was defined as reducing protein in the urine to ≤0.5 mg/mg, while helping maintain kidney function.
cThe odds ratio was 2.7.
dOn average after six months of treatment compared to a year for patients only taking MMF and steroids.
Since starting on LUPKYNIS,
I slowly resumed
some of
my normal activities I had
done prior
to my diagnosis.
That was such a great thing.
—Suriya, started treatment
in 2021
Feel confident talking to your doctor about LUPKYNIS
Our downloadable doctor discussion guide can help make starting the conversation easier.